Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Human Genome Sciences, Inc. (HGSI) -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (662)	11/20/2001 3:19:29 AM
From: Icebrg	Read Replies (1) \| Respond to of 1127

This looks very much like the work being done by Vascular Genetics. EART RESEARCH - Successes of Gene Therapy By JANE E. ALLEN {LA]TIMES HEALTH WRITER November 19 2001 An experimental gene therapy used in critically ill heart patients has shown significant potential for restoring blood flow in clogged cardiac vessels, reducing chest pain and enhancing quality of life. These successes, which have been demonstrated in a handful of small research studies so far, are drawing attention to a technique that appears to stimulate growth of new blood vessels. If the results are duplicated in larger studies, gene therapy may one day become an important tool in the fight against coronary artery disease. Message 16683009